openPR Logo
Press release

A Complete Study Guide to Cardiovascular Devices

12-11-2025 07:24 AM CET | Health & Medicine

Press release from: The Insight Partners

The cardiovascular devices is estimated to grow owing to key driving factors such as increasing prevalence of cardiovascular diseases and rising number of product launches & approvals. In the last decade, the world witnessed notable developments in cardiovascular devices, aiding physicians and patients with new approaches to managing atrial arrhythmias, ventricular arrhythmias, and ventricular atrial fibrillation, among other medical conditions. The growing prevalence of arrhythmia and other cardiovascular diseases (CVDs) is encouraging the introduction of improved cardiovascular devices. The rapidly increasing prevalence of CVDs is raising the demand for technically advanced devices for diagnosing and treating patients with effective and efficient care. For instance, in October 2022, The US FDA approved Medtronic plc's request to broaden the labeling of a cardiac lead. This lead allows patients to obtain necessary therapy without running the risk of consequences like cardiomyopathy that might arise from using more conventional pacing methods.

Get a PDF Copy: https://www.theinsightpartners.com/sample/TIPHE100000826/?utm_source=OpenPR&utm_medium=10914

Top Key Players are include:
• Medtronic
• Boston Scientific Corporation
• Abbott
• Biosense Webster, Inc. (Johnson and Johnson)
• General Electric Company
• Koninklijke Philips N.V
• Siemens AG
• BD
• B. Braun Melsungen AG
• Edwards Lifesciences Corporation

Contact Us:
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A Complete Study Guide to Cardiovascular Devices here

News-ID: 4310802 • Views:

More Releases from The Insight Partners

A Complete Study Guide to Clinical Trials
A Complete Study Guide to Clinical Trials
The clinical trial market is mainly driven by continuous efforts made by pharmaceutical, biotechnology, and medical device companies for product innovations. Other factors contributing to the market progress include the globalization of clinical trials, rapid advancements in associated technologies, and an increase in demand for CROs for conducting clinical trials. Increasing strategic initiatives by companies such as product launches, mergers and acquisitions, partnerships, and geographic expansions benefit the clinical trials
A Complete Study Guide to Clinical Trials
A Complete Study Guide to Clinical Trials
The clinical trial market is mainly driven by continuous efforts made by pharmaceutical, biotechnology, and medical device companies for product innovations. Other factors contributing to the market progress include the globalization of clinical trials, rapid advancements in associated technologies, and an increase in demand for CROs for conducting clinical trials. Increasing strategic initiatives by companies such as product launches, mergers and acquisitions, partnerships, and geographic expansions benefit the clinical trials
Drug Discovery Services Market Analysis, Size, Growth and Share by 2030
Drug Discovery Services Market Analysis, Size, Growth and Share by 2030
A Complete Study Guide to Drug Discovery Services Drug discovery is the process of identifying or developing new medications to treat diseases and improve human health. It involves the identification of potential drug candidates in stages ranging from their synthesis to testing in laboratories and animal models, and evaluation in human trials. Drug discovery service providers offer specialized expertise and resources to support the drug discovery process. This can include medicinal
Protein Powder Market Evolution: Global Trends, Regional Growth, and 2031 Outlook
Protein Powder Market Evolution: Global Trends, Regional Growth, and 2031 Outloo …
The protein powder market size is projected to reach US$ 39.15 billion by 2031 from US$ 24.39 billion in 2023. The market is expected to register a CAGR of 6.1% during 2023-2031. Growing demand for plant-based protein powders and increased heath awareness are likely to remain key trends in the market. The protein powder market has been growing significantly during the forecast period. North America has emerged as a major contributor

All 5 Releases


More Releases for CVDs

Global Cardiovascular Diagnostic & Monitoring Devices Market to Reach Over USD 2 …
The global cardiovascular diagnostic & monitoring devices market, valued at USD 14.2 billion in 2021, is projected to nearly double to over USD 29.0 billion by the end of 2031, expanding at a robust CAGR of 7.5% over the forecast period (2022-2031). Fueled by the surging burden of chronic cardiovascular diseases (CVDs), demand for early diagnosis, and rapid technological advancements including AI‐enabled monitors and minimally invasive implants the market presents
Contrast Enhanced Ultrasound Market by Product (Equipment, Nanoparticle & Molecu …
"The contrast-enhanced ultrasound market is projected to grow at a CAGR of 6.1% during the forecast period (2023-2028)." The global contrast-enhanced ultrasound market is projected to reach USD 2.1 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 6.1% from 2023 to 2028. Factors such as rising geriatric population and increasing use of contrast agents are responsible for the increasing growth of this market. Increasing research and
RAS-acting Agents Market to Reach US$ 13.4 Billion by 2031 Due to Increase in pr …
The global 𝗥𝗔𝗦-𝗮𝗰𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗻𝘁𝘀 market is estimated to attain a valuation of US$ 13.4 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.2% during the forecast period, 2023-2031. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of
Ventricular Assist Devices Market to Reach US$ 2.80 Billion by 2027, Fueled by R …
According to the latest report by IMARC Group, titled "Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global ventricular assist devices market reached a value of US$ 1.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.80 Billion by 2027, exhibiting at a CAGR of 10.09% during 2022-2027. A ventricular assist device (VAD), also called a mechanical circulatory
Rising Prevalence of CVDs Leads to Increasing Demand for Cardiac Biomarkers
In 2021, the cardiac biomarkers industry contributes $8,459.6 million, and it is projected to rise at a rate of 10.5%, to capture $20,718.8 million revenue in 2030. It is led by the rising prevalence of acute coronary syndrome, increasing point-of-care testing kit demand, and technological advancements in the industry. Moreover, the surging investments in biomarker research, increasing CVDs incidences, and rising geriatric population are projected to boost the industry growth.
Global rise in the incidence and prevalence rate of cardiovascular diseases (CVD …
Global Cardiovascular Information Systems (Cvis) Market is projected to grow at a considerable growth rate owing to increasing prevalence of CVDs across the globe. According to WHO, in 2018, CVDs accounts for 17.7 million mortality per year, which means 31% mortalities across the globe. The CVIS systems support in the assessment of chronic conditions such as CHD (coronary heart disease), stroke, and other heart related disease. CVIS systems allow assembling